REQUEST A DEMO
Total
USD $0.00
Search more companies

Biolovet C.A. (Ecuador)

Main Activities: Pharmacies and Drug Stores
Full name: Biolovet C.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biolovet C.A. is a company in Ecuador, with a head office in Guayaquil. The company operates in the Pharmacies and Drug Stores industry. It was first established on November 27, 1990. 21 (2023) employees currently work for Biolovet C.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 1.56% in 2023. There was a total growth of 4.51% in Biolovet C.A.’s total assets over the same period. In 2023, Biolovet C.A.’s net profit margin decreased by 2.69%.

Headquarters
Principal Mz. 21 V.1
Guayaquil; Guayas;

Contact Details: Purchase the Biolovet C.A. report to view the information.

Basic Information
Total Employees:
Purchase the Biolovet C.A. report to view the information.
Outstanding Shares:
Purchase the Biolovet C.A. report to view the information.
Registered Capital:
Purchase the Biolovet C.A. report to view the information.
Incorporation Date:
November 27, 1990
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.97%
Purchase this report to view the information.
0.03%
Company Performance
Financial values in the chart are available after Biolovet C.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
1.56%
Total operating revenue
1.56%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-62.81%
Total assets
4.51%
Total equity
24.37%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-2.69%
Return on Equity (ROE)
-8.07%
Debt to Equity Ratio
-18.13%
Quick Ratio
-6.12%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?